Logos Global Management LP
Annual return '25
+25.6%
SPY '25
+17.7%
Alpha
+7.9ptsvs SPY
Invested
$2B
Holdings
63
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 96%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$RVMD
REVOLUTION MEDICINES INC
Q4 2025: Exited (was 3.50M shares)
9.7%
02
$ERAS
ERASCA INC
Q4 2025: Exited (was 15.15M shares)
9.0%
03
$IDYA
IDEAYA BIOSCIENCES INC
Q4 2025: Exited (was 4.50M shares)
5.7%
04
$TERN
TERNS PHARMACEUTICALS INC
Held since at least Q1 2024
5.3%
05
$PRAX
PRAXIS PRECISION MEDICINES I
Q4 2025: Exited (was 125.0k shares)
4.6%
06
$CNTA
CENTESSA PHARMACEUTICALS PLC
Q4 2025: Exited (was 525.0k shares)
4.2%
07
$ABVX
ABIVAX SA
Q4 2025: Exited (was 415.0k shares)
3.8%
08
$TNGX
TANGO THERAPEUTICS INC
Q4 2025: Exited (was 950.0k shares)
3.1%
09
$CYTK
CYTOKINETICS INC
Q1 2025: Exited (was 900.0k shares)
2.9%
10
$OLMA
OLEMA PHARMACEUTICALS INC
Q4 2025: Exited (was 3.21M shares)
2.4%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:34 UTC.